VCP
CSII

Verus Capital Partners’s Cardiovascular Systems, Inc. CSII Stock Holding History

Verus Capital Partners’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$14K Hold
400
– – ﹤0.01% 922
2019
Q4 		$19K Buy
+400
New +$18.2K 0.01% 937

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verus Capital Partners's CSII Position: Q1 2020 in Review

Verus Capital Partners held its Cardiovascular Systems, Inc. (CSII) position steady in Q1 2020 at 400 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Verus Capital Partners first reported a position in CSII in Q4 2019 and has held it in 2 quarters since. The position peaked at $19K in Q4 2019. 183 funds tracked by Wall St. Rank hold CSII as of Q1 2020.

  • Verus Capital Partners held 400 shares of Cardiovascular Systems, Inc. worth $14K as of Q1 2020.
  • Verus Capital Partners left its Cardiovascular Systems, Inc. share count unchanged in Q1 2020.
  • Cardiovascular Systems, Inc. made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #922 holding.
  • Verus Capital Partners first reported a position in Cardiovascular Systems, Inc. in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Cardiovascular Systems, Inc. position peaked at $19K in Q4 2019.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.